Prevail Therapeutics are developing novel gene therapies that target the root genetic causes of Parkinson’s disease and other neurodegenerative disorders. 

Biotechnology

Prevail Therapeutics

Prevail Therapeutics' headquarters in New York, NY, United States

Franz Hefti

Mansuo Lu Shannon

The Scientific Research and Development team at Prevail Therapeutics is dedicated to discovering and developing innovative gene therapies that target the genetic causes of Parkinson's disease and other neurodegenerative disorders. This team conducts cutting-edge research, performs preclinical studies, and advances the understanding of disease mechanisms to drive the development of effective gene therapy treatments.

Scientific Research and Development

The Leadership Team at Prevail Therapeutics spearheads the strategic direction and overall vision of the company, focusing on the development and advancement of innovative gene therapies for Parkinson’s disease and other neurodegenerative disorders. They oversee critical areas such as research and development, clinical operations, and regulatory compliance, ensuring that the company's mission to address the root genetic causes of these diseases is effectively executed. Together, they foster collaboration across disciplines to drive scientific discovery and bring therapies from concept to clinical application.

Prevail Therapeutics

Org chart

Teams

Scientific Research and Development

Leadership Team

Offices

Prevail Therapeutics

Org chart

Teams

Scientific Research and Development

Leadership Team

Offices

Related companies